Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
ADMA Biologics is a US-based biopharmaceutical company focused on developing, manufacturing, and commercializing plasma-derived biologics. These life-saving therapies target patients with primary immunodeficiencies and rare neurological diseases. The company enhances quality of life through innovative immunoglobulin products.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
ADMA Biologics is scheduled to report its next quarterly earnings on 11/11/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
ADMA Biologics last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at 0.16 USD.
Across its last 3 earnings reports, ADMA Biologics stock moved by ±9.3% on average the following day. The largest reaction was -16% on 05/06/2026; 0 of 3 reactions were positive.
ADMA Biologics has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.